The authors demonstrated the ability of DEM-B12 to release both the water-soluble 5-FU and lipidic ruthenium complex in cancer cells thanks to an efficient interaction with the transcobalamin receptor [43] (Table 1). This evidence concerns the gene CD320 and cancer.